| Bioactivity | Anti-inflammatory agent 22 (compound 14a) is an orally active anti-inflammatory agent. Anti-inflammatory agent 22 inhibits LPS-induced TNF-α production with an IC50 value of 14.6 μM. Anti-inflammatory agent 22 has preventive effects on lymphedematous tissue via suppression of adipogenesis. Anti-inflammatory agent 22 suppresses limb lymphedema volume in mice[1]. |
| Name | Anti-inflammatory agent 22 |
| CAS | 2721484-76-8 |
| Formula | C22H16O6 |
| Molar Mass | 376.36 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Roh K, et al. Synthesis and evaluation of butein derivatives for in vitro and in vivo inflammatory response suppression in lymphedema. Eur J Med Chem. 2020;197:112280. |
Anti-inflammatory agent 22
CAS: 2721484-76-8 F: C22H16O6 W: 376.36
Anti-inflammatory agent 22 (compound 14a) is an orally active anti-inflammatory agent. Anti-inflammatory agent 22 inhibi
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.